8 results on '"Nedim Yılmaz Selçuk"'
Search Results
2. A Rare Case: Improved Heart Failure with Anti-Complement Therapy in Complement-Dependent Hemolytic Uremic Syndrome
- Author
-
Hakan Özer, Yasin Öztürk, Kültigin Türkmen, Zeki Halil Tonbul, and Nedim Yılmaz Selçuk
- Subjects
Internal medicine ,RC31-1245 ,Pediatrics ,RJ1-570 - Published
- 2023
- Full Text
- View/download PDF
3. Clinical and histopathological characteristics of primary focal segmental glomerulosclerosis in Turkish adults
- Author
-
Ilhan Kurultak, Ozkan Gungor, Savas Ozturk, Ahmet Burak Dirim, Necmi Eren, Ezgi Yenigün, Elbis Ahbab Dal, Mevlut Tamer Dincer, Feyza Bora, Suat Akgur, Abdullah Sumnu, Belda Dursun, Savas Sipahi, Hakki Cetinkaya, Idris Sahin, Garip Sahin, Murvet Yilmaz, Bulent Vatansever, Emre Aydın, Memnune Sena Ulu, Ali Gundogdu, Sedat Ustundag, Hayriye Sayarlioglu, Gizem Kumru, Omer C. Elcioglu, Zeki Aydın, Nedim Yılmaz Selcuk, Ceren Onal Guclu, Meric Oruc, Mehmet Kucuk, Nimet Aktas, Ulver Derici, and Gultekin Suleymanlar
- Subjects
FSGS ,Histopathological features ,Nephrotic syndrome ,Primary focal segmental glomerulosclerosis ,Turkish adults ,Medicine ,Science - Abstract
Abstract The data regarding primary FSGS (pFSGS) from different parts of the world differ. While the prevalence of pFSGS has been increasing in Western countries like the USA, it follows an inconsistent trend in Europe and Asia and a decreasing trend in Far Eastern countries such as China in the last two decades. There are undetermined factors to explain those national and geographic discrepancies. Herein, we aimed to reveal the current prevalence with clinical and histopathological characteristics of pFSGS in Turkish adults. This study includes the biopsy-proven pFSGS patients data recorded between 2009 and 2019, obtained from the national multicenter primary glomerulonephritis registry system of the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) database. 850 of the 3875 primer glomerulonephritis patients(21.9%) have pFSGS. The mean age is 40.5 ± 14.2 and 435 (51.2%) of patients are male. Nephrotic syndrome is the most common biopsy indication (59.2%). 32.6% of patients have hematuria, 15.2% have leukocyturia and 7.8% have both. Serum creatinine, albumin, and proteinuria are 1.0 mg/dL (IQR = 0.7–1.4) mg/dl, 3.4 ± 0.9 g/dl, 3400 mg/day(IQR, 1774–5740), respectively. Females have lower mean arterial pressure (− 2.2 mmHg), higher eGFR (+ 10.0 mL/min/1.73 m2), and BMI (+ 1.6 kg/m2) than males. Thickened basal membrane(76.6%) and mesangial proliferation (53.5%) on light microscopy are the major findings after segmental sclerosis. IgM (32.7%) and C3 (32.9%) depositions are the most common findings on immunofluorescence microscopy. IgM positivity is related to lower eGFR, serum albumin, and higher proteinuria. The prevalence of pFSGS is stable although slightly increasing in Turkish adults. The characteristics of the patients are similar to those seen in Western countries.
- Published
- 2024
- Full Text
- View/download PDF
4. Trends of primary glomerular disease in Turkey: TSN-GOLD registry report
- Author
-
Cuma Bülent Gül, Mehmet Küçük, Savaş Öztürk, Erol Demir, Necmi Eren, Abdullah Şumnu, Nurhan Seyahi, Mustafa Güllülü, Fatih Dede, Ülver Derici, Yener Koç, Garip Şahin, Oktay Oymak, Gülizar Manga Sahin, Erhan Tatar, Belda Dursun, Hamad Dheir, Süheyla Apaydın, Gültekin Süleymanlar, Sena Ulu, Orçun Altınören, Sim Kutlay, Meral Meşe, İdris Şahin, Sedat Üstündağ, Kültigin Türkmen, Mehmet Emin Yılmaz, Rümeyza Turan Kazancıoğlu, Özcan Uzun, Ferhan Candan, Zeki Aydın, Deren Oygar, Nimet Aktaş, Yunus Erdem, Saime Paydaş, Dilek Taymez, Başak Can, Ahmet Kıykım, Leyla Koç, Siren Sezer, Murat Duranay, Simge Bardak, Lütfullah Altıntepe, Burcu Kaya, Alper Azak, Sebahat Alışır Ecder, Caner Çavdar, Nedim Yılmaz Selçuk, Dicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıklar Ana Bilim Dalı, Yılmaz, Mehmet Emin, KAZANCIOĞLU, Rümeyza, and Gul C. B., Kucuk M., Ozturk S., Demir E., EREN N., Sumnu A., SEYAHİ N., Gullulu M., Dede F., DERİCİ Ü., et al.
- Subjects
Internal Diseases ,IGA NEPHROPATHY ,Male ,PRIMARY GLOMERULONEPHRITIS ,Turkey ,retrospective study ,Biopsy ,audiography ,immunoglobulin A ,Sağlık Bilimleri ,Kidney ,Turkey (republic) ,İç Hastalıkları ,Clinical Medicine (MED) ,computer assisted tomography ,immunoglobulin G ,Glomerulonephritis ,creatinine clearance ,EPIDEMIOLOGY ,Ureteral Diseases ,Klinik Tıp (MED) ,RENAL BIOPSY ,Registries ,nuclear magnetic resonance imaging ,thorax radiography ,register ,Klinik Tıp ,nephrotic syndrome ,ultrasound ,adult ,SPANISH REGISTRY ,ureter disease ,vascular disease ,genetic screening ,IgA nephropathy ,Primary glomerulopathy ,Tıp ,PREVALENCE ,protein electrophoresis ,Nefroloji ,Nephrology ,laboratory test ,eye examination ,Medicine ,Female ,alanine aminotransferase ,Urology ,kidney biopsy ,FREQUENCY ,DIAGNOSIS ,Article ,glomerulopathy ,uric acid ,turkey (bird) ,UROLOGY & NEPHROLOGY ,Health Sciences ,Humans ,human ,Vascular Diseases ,immunofluorescence ,immunoglobulin A nephropathy ,ÜROLOJİ VE NEFROLOJİ ,Aged ,Retrospective Studies ,TSN-GOLD registry report.-, International urology and nephrology, 2022 [Gül C. B. , Küçük M., Öztürk S., Demir E., Eren N., Şumnu A., Seyahi N., Güllülü M., Dede F., Derici Ü., et al., -Trends of primary glomerular disease in Turkey] ,Internal Medicine Sciences ,electron microscopy ,Kidney biopsy registry ,Glomerulonephritis, IGA ,Dahili Tıp Bilimleri ,ADULTS ,CLINICAL MEDICINE ,NATIONWIDE ,hepatitis B surface antigen ,FSGS ,pathology ,blood cell count ,trend study - Abstract
Background: Although several renal biopsy registry reports have been published worldwide, there are no data on primary glomerular disease trends in Turkey. Methods: Three thousand eight-hundred fifty-eight native kidney biopsy records were assessed in the Turkish Society of Nephrology Primary Glomerulopathy Working Group (TSN-GOLD) Registry. Secondary disease and transplant biopsies were not recorded in the registry. These records were divided into four periods, before 2009, 2009 to 2013, 2013–2017, and 2017–current. Results: A total of 3858 patients (43.6% female, 6.8% elderly) were examined. Nephrotic syndrome was the most common biopsy indication in all periods (58.6%, 53%, 44.1%, 51.6%, respectively). In the whole cohort, IgA nephropathy (IgAN) (25.7%) was the most common PGN with male predominance (62.7%), and IgAN frequency steadily increased through the periods (× 2 = 198, p < 0.001). MGN was the most common nephropathy in the elderly (> 65 years), and there was no trend in this age group. An increasing trend was seen in the frequency of overweight patients (× 2 = 37, p < 0.0001). Although the biopsy rate performed with interventional radiology gradually increased, the mean glomeruli count in the samples did not change over the periods. Conclusions: In Turkey, IgAN is the most common primary glomerulonephritis, and the frequency of this is increasing. © 2022, The Author(s), under exclusive licence to Springer Nature B.V.
- Published
- 2021
5. Are Kidney Donor Risk Index/Kidney Donor Profile Index Scores Predictor of Future Graft Function?
- Author
-
Ismail Baloglu, Halil Zeki Tonbul, Kultigin Turkmen, Nedim Yilmaz Selcuk, and Mehmet Sinan Iyisoy
- Subjects
Medicine - Abstract
Kidney donor profile index (KDPI) is a method developed to assess donor kidney quality for cadaveric transplants. We investigated the relationship between kidney donor risk index (KDRI) and KDPI scores of cadaveric transplants in the last five years in our clinic and current graft conditions. Forty people (12 females, 28 males; mean age, 46.35 + 8.94 years), who underwent cadaveric transplantation between January 2013 and March 2018, were participated in this study. At the same time, the KPDI and KDRI scores of the donor’s kidneys were calculated and then compared with that of the recipients’ data. The mean KDRI value of donors was 1.11 ± 0.33 and the median KDPI value was 60.50%. KDRI/KDPI scores were found to be high in women (P = 0.021) and, when the posttransplant findings of the recipients were evaluated by bivariate correlation analysis KDRI/KDPI scores were positively correlated with the day when creatinine (Cr) values started to fall off spontaneously (r = 0.457, P = 0.003). It was observed that recipients who were transplanted from the donors with high KDRI/KDPI scores had higher Cr levels (P
- Published
- 2021
- Full Text
- View/download PDF
6. A Rare Case: Improved Heart Failure with Anti-Complement Therapy in Complement-Dependent Hemolytic Uremic Syndrome
- Author
-
Özer, Hakan, Öztürk, Yasin, Türkmen, Kültigin, Tonbul, Halil Zeki, Selçuk, Nedim Yılmaz, Hakan Özer: 0000-0001-9174-0351, Yasin Öztürk: 0000-0003-2634-2677, Kültigin Türkmen: 0000-0002-1667-7716, Halil Zeki Tonbul: 0000-0003-0761-3697, Nedim Yılmaz Selçuk: 0000-0003-0836-7993, and NEÜ, Meram Tıp Fakültesi, Dahili Tıp Bilimleri, İç Hastalıklar Anabilim Dalı
- Subjects
Heart Failure ,Anti-Complement Therapy ,Thrombotic Microangiopathy ,Complement-Mediated Kemolytic-Uremic Syndrome ,Acute Kidney Injury - Abstract
Makale, WOS:000925209300014, xtrarenal involvement occurs in approximately 20% of patients with complement-mediated hemolytic-uremic syndrome. The involvement is usually of the nervous system, and cardiac involvement occurs in 3%-10% of patients. Cardiac manifestations vary, including myocardial infarction, cardiomyopathy, and acute decompensated heart failure. Among these patients, thrombotic microangiopathy-related cardiac dysfunction is mainly due to the continuous activation of the complement system, which leads to endothelial damage and thrombosis in the coronary microvessels. We wanted to highlight the importance of cardiac evaluation at the time of diagnosis or during follow-up in thrombotic micro-angiopathy patients by presenting a case of heart failure with low ejection fraction in a 24-year-old young patient in whom we detected complement-mediated hemolytic-uremic syndrome, a secondary mutation of complement factor H receptor. It is still an unknown issue because of the rarity of cardiac involvement in complement-mediated hemolytic-uremic syndrome patients. Primary myocardial involvement is increasingly recognized as a possible concomitant feature of hemolytic-uremic syndrome. Failure to perform a detailed cardiac evaluation both at diagnosis and during follow-up in complement-mediated hemolytic-uremic syndrome patients can lead to fatal outcomes. Anti-complement therapy can also lead to good cardiac outcomes in these patients.
- Published
- 2023
7. Hemodiyaliz Hastalarında İki Farklı Bikarbonat İçerikli Diyalizat Kullanımının Asidoz Kontrolüne Etkisi
- Author
-
Türkmen Kültigin, Ismail Baloglu, Nedim Yilmaz Selcuk, Halil Zeki Tonbul, Kültigin Türkmen: 0000-0002-1667-7716, Nedim Yılmaz Selçuk: 0000-0003-0836-7993, İsmail Baloğlu: 0000-0002-8751-5490, and Necmettin Erbakan Üniversitesi Meram Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü İç Hastalıkları Anabilim Dalı
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Urology ,Medicine ,Surgery ,business - Abstract
AMAÇ: Hemodiyaliz hastalarında kronik bir metabolik asidoz eğilimi söz konusudur. Yüksek olgu sayılı çalışmalarda diyaliz öncesi serum bikarbonat konsantrasyonu ile mortalite arasında ilişki saptanmıştır. Çalışmamızda 32 ve 36 mmol/L bikarbonat içerikli diyaliz solüsyonu kullanımının asidoz kontrolüne etkisi araştırıldı.GErEÇ ve YÖnTEMLEr: Bir merkezde haftada üç kez hemodiyalize giren 91 (43E,48K) hastaya ilk altı ay 32 mmol/L diyalizat, ikinci altı ayda aynı hastalara 36 mmol/L bikarbonat diyalizat kullanılmaya başlandı ve diyaliz öncesi ve sonrası plazma bikarbonat düzeyleri karşılaştırıldı. BULGULAr: İlk altı ayda ortalama bikarbonat düzeyi 20,552,55 mmol/L olup sadece 30 hastada bikarbonat düzeyi 22 mmol/L ve üzerindeydi. İkinci altı aylık dönemde ise ortalama bikarbonat düzeyi 23,593,3 mmol/L olup hedef düzeylerdeydi. Ancak 19 hastada diyaliz sonu ortalama bikarbonat düzeyi 30 mmol/L'nin üzerinde bulundu. Prediyaliz asidozu olan hastaların ortalama interdiyalitik kilo artışı 2,80,5 kg olup, asidozu olmayan gruptan daha yüksekti (p0,05). Prediyaliz üre, Kt/V, albumin, potasyum ve CRP düzeyleri bakımından iki periyot arasında anlamlı farklılık yoktu. SOnUÇ: 36 mmol/L bikarbonat içeren diyaliz solüsyonu kullanımı ile asidoz kontrolü daha iyi yapılmakta ancak hastaların yaklaşık yüzde yirmisinde diyaliz sonunda ciddi metabolik alkaloz gelişmektedir. Bu durum aritmiyi tetikleyebilir. Bu nedenle aritmisi olan veya metabolik alkaloza eğilimi olan hastalarda yüksek bikarbonatlı solüsyon kullanımında bikarbonat içeriğinin ayarlanmasının gerektiğini düşünmekteyiz., OBJECTIVE: In hemodialysis patients; there is a continuing tendency to metabolic acidosis. In studies, the relationship between serum bicarbonate concentration and dialysis mortality has been determined. In our study, the effect of 32 and 36 mmol/L bicarbonate-containing dialysis solution on acidosis control was investigated. MATErıAL and METHODS: In a hemodialysis clinic, a 32 mmol/L bicarbonate-containing dialysate was used in the first six months and a 36 mmol/L bicarbonate-containing dialysate was used in the second six months. The study was performed on 91 (43M/48F) patients. Plasma bicarbonate levels before and after dialysis were compared. rESULTS: In the first period, only 30 patients' bicarbonate levels were 22 mmol/L or more. In the second period, the mean bicarbonate level was 23.59±3.3 mmol/L. However, the level of bicarbonate after dialysis was above 30 mmol/L in 19 patients. In patients with predialysis acidosis, the interdialytic mean weight gain was higher than in the group without acidosis (p>0.05). There were no significant differences between the two periods in terms of predialysis urea, Kt/V, albumin, potassium and CRP levels.CONClUSION: Acidosis control is better with the use of a dialysis solution containing 36 mmol/L bicarbonate. But at the end of dialysis, severe metabolic alkalosis developed on approximately twenty percent of patients. This situation can trigger arrhythmia. We therefore think that it is necessary to adjust the machine bicarbonate in the use of high bicarbonate solution in patients with arrhythmia or alkalosis tendency.
- Published
- 2017
8. Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up
- Author
-
Ramazan Ucar, Ahmet Zafer Caliskaner, Nedim Yilmaz Selcuk, Şevket Arslan, Huseyin Ataseven, Ismail Reisli, İsmail Reisli: 0000-0001-8247-6405, Şevket Arslan: 0000-0002-0343-0159, Hüseyin Ataseven: 0000-0001-8515-8760, Nedim Yılmaz Selçuk: 0000-0003-0836-7993, Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalı, and Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Anabilim Dalı
- Subjects
Adult ,0301 basic medicine ,Cvıd Management ,Pediatrics ,medicine.medical_specialty ,Cvıd Follow-Up ,Turkey ,Long term follow up ,Treatment results ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Cvıd İn Adults ,Health care ,Humans ,Medicine ,Medical history ,In patient ,Common Variable İmmunodeficiency ,Cerrahi ,Bronchiectasis ,business.industry ,Common variable immunodeficiency ,Common variable immunodeficiency,CVID in adults,CVID management,CVID follow-up ,General Medicine ,Middle Aged ,medicine.disease ,Common Variable Immunodeficiency ,030104 developmental biology ,Quality of Life ,business ,Follow-Up Studies ,030215 immunology - Abstract
WOS:000370271100029, PubMed ID: 27511507, Background/aim: The aim of this study is to establish follow-up protocols for adult patients with common variable immunodeficiency (CVID) in a recently founded adult immunology clinic in the Central Anatolia Region of Turkey, where a clinical immunology center for adults was not available previously. Materials and methods: A total of 25 patients with CVID aged 18 years and older were included in this study. The file format consisted of 13 pages and was developed for the purpose of the study. Separate sections were designated for identity information, medical history, disease course, previous and current laboratory and imaging studies, follow-up plans, detection and management of complications/ comorbidities, and treatment results. Results: The mean age of the patients was 36.6 ± 13.4 years. The delay in diagnosis was 107 ± 95.6 months. In 92% of patients, initial symptoms resulting in admission to healthcare facilities were infections. Seventeen of 25 patients (68%) had bronchiectasis at the beginning of follow-up. Conclusion: Early identification of complications and comorbidities in patients with CVID will significantly improve quality of life and survival. Close observation and standardized protocols for follow-up are essential components of management.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.